October - LRS Institute of Tuberculosis & Respiratory Diseases
October - LRS Institute of Tuberculosis & Respiratory Diseases
October - LRS Institute of Tuberculosis & Respiratory Diseases
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
VISUAL PATTERN IN ETHAMBUTOL TREATED TUBERCULAR PATIENTS 223<br />
symptoms were recorded earliest after 4 months<br />
<strong>of</strong> therapy in 2 cases, but in a majority <strong>of</strong> the<br />
cases the appearance <strong>of</strong> the symptoms was a<br />
late feature. (Table 3). In no case symptoms<br />
developed after It months <strong>of</strong> treatment.<br />
TABLE 3<br />
Time <strong>of</strong> Appearance <strong>of</strong> Symptoms<br />
Time <strong>of</strong> appearance <strong>of</strong> symptom<br />
4 Months<br />
5 Months<br />
6 Months<br />
8 Months<br />
11 Months<br />
No. <strong>of</strong> patients<br />
2<br />
1<br />
2<br />
7<br />
12<br />
1360 eyes had normal 6/6 vision but after<br />
18 months <strong>of</strong> therapy their number came down<br />
to 368 The range <strong>of</strong> deterioration <strong>of</strong> vision is<br />
shown in Table 5. The near vision acuity<br />
also showed a similar pattern <strong>of</strong> change. In<br />
the symptomatic group no visual disturbance<br />
was noted prior to development <strong>of</strong> symptoms<br />
while in asymptomatic group <strong>of</strong> patients (57<br />
cases) the visual function disturbance was noted<br />
for the first time only after 7 months <strong>of</strong> therapy<br />
(in 11 cases). No visual disturbance was noticed<br />
in any case after the treatment had continued<br />
for 12 months (Table 6).<br />
Visual field examination revealed that central<br />
and paraccntral fields were normal with both<br />
white and coloured targets, before as well as<br />
after the therapy in all the cases included in<br />
the present study. However, the peripheral<br />
fields were normal for white, blue and red colors<br />
in all the patients before as well as after the completion<br />
<strong>of</strong> therapy but were found to have changed<br />
in their normal relative extent for green<br />
color (isoptre 5/330) in 71 eyes <strong>of</strong> 39 cases.<br />
32 patients had bilateral while 7 cases had<br />
TABLE 4<br />
Age & Sex distribution <strong>of</strong> patients having visual function disturbance during Ethambutol therapy.<br />
Age Group Symptomatic patients Asymptomatic patients<br />
Males Female Total Males Females Total<br />
Below 20 years 1 ____ 1 2 2 4<br />
20 + to 30 yrs 10 4 14 24 10 34<br />
30 + to 40 yrs 4 2 6 9 3 12<br />
40 + and above 2 1 3 4 3 7<br />
Total 17 7 24 39 18 57<br />
Routine monthly examination revealed a<br />
diminution <strong>of</strong> visual acuity in 81 patients<br />
though only 24 patients had suggestive<br />
symptoms. The age and sex distribution <strong>of</strong> the<br />
24 symptomatic and 57 asymptomatic patients<br />
is given in Table 4 The proportion <strong>of</strong> males<br />
and females in both the groups is nearly the<br />
same.<br />
It can be seen from Table 5 that before<br />
the start <strong>of</strong> Ethambutol therapy, 1200 <strong>of</strong> the<br />
unilateral eye involvement. As regards the green<br />
field changes (77) the range <strong>of</strong> diminution for<br />
green fields was 4° to 7° in various meridians.<br />
Fund us examination did not show any striking<br />
change during the course <strong>of</strong> therapy except<br />
for mild to moderate hyperemia <strong>of</strong> the optic<br />
disc in majority <strong>of</strong> cases. In all the 81 patients,<br />
who developed visual function disturbances<br />
the ethambutol therapy was discontinued,<br />
no sooner the visual function disturbance was<br />
Ind. J. Tub., Vol. XXIX, No. 4